C C Haudenschild
Overview
Explore the profile of C C Haudenschild including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefansson S, Haudenschild C, Lawrence D
Trends Cardiovasc Med
. 2011 Jan;
8(4):175-80.
PMID: 21235930
Plasminogen activator inhibitor-1 (PAI-1), as the name implies, is the primary in vivo inhibitor of both tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). PAI-1 also binds to other...
2.
Barton M, Haudenschild C
J Cardiovasc Pharmacol
. 2002 Jan;
38 Suppl 2:S23-5.
PMID: 11811371
Atherosclerosis, a chronic systemic disease of the vasculature with an inflammatory component, is the primary cause of cardiovascular morbidity and mortality in industrialized countries. Impairment of vascular endothelial cell function...
3.
Li Y, Tondravi M, Liu J, Smith E, Haudenschild C, Kaczmarek M, et al.
Cancer Res
. 2001 Sep;
61(18):6906-11.
PMID: 11559568
Gene amplification of the chromosome 11q13 in breast cancer and squamous carcinomas in the head and neck results in frequent overexpression of cortactin, a prominent substrate of Src-related tyrosine kinases...
4.
Kipshidze N, Ferguson 3rd J, Keelan Jr M, Sahota H, Komorowski R, Shankar L, et al.
J Am Coll Cardiol
. 2000 Oct;
36(4):1396-403.
PMID: 11028501
Objectives: The objectives of this study were 1) to improve the attachment of reimplanted endothelial cells (EC) using a fibrin glue, and 2) to assess the impact of endothelial reseeding...
5.
Qian J, Burkly L, Smith E, Ferrant J, HOYER L, Scott D, et al.
Eur J Immunol
. 2000 Sep;
30(9):2548-54.
PMID: 11009088
Using the murine model of hemophilia A, we have examined the role of CD154 in the secondary immune response to factor VIII (FVIII). We previously reported that repeated i.v. injection...
6.
Kipshidze N, Johnson W, Haudenschild C
J Invasive Cardiol
. 2000 Apr;
11(10):589-99.
PMID: 10745440
No abstract available.
7.
Dugi K, Amar M, Haudenschild C, Shamburek R, Bensadoun A, Hoyt Jr R, et al.
Arterioscler Thromb Vasc Biol
. 2000 Mar;
20(3):793-800.
PMID: 10712405
To investigate the in vivo role that hepatic lipase (HL) plays in HDL metabolism independently of its lipolytic function, recombinant adenovirus (rAdV) expressing native HL, catalytically inactive HL (HL-145G), and...
8.
Barton M, Carmona R, Morawietz H, dUscio L, Goettsch W, Hillen H, et al.
Hypertension
. 2000 Jan;
35(1 Pt 2):329-36.
PMID: 10642320
In the C57BL/6J mice model, we investigated whether obesity affects the function or expression of components of the tissue renin-angiotensin system and whether endothelin (ET)-1 contributes to these changes. ACE...
9.
Tjurmin A, Ananyeva N, Smith E, Gao Y, Hong M, Leon M, et al.
Arterioscler Thromb Vasc Biol
. 1999 Jan;
19(1):83-97.
PMID: 9888870
Myxomatous tissue is a characteristic component of human coronary artery lesions, found more often in restenotic lesions. It represents a bulky accumulation of stellate-shaped cells of unknown histogenesis that are...
10.
Kornowski R, Hong M, Haudenschild C, Leon M
Coron Artery Dis
. 1998 Dec;
9(8):535-40.
PMID: 9847986
Background: Direct myocardial revascularization (DMR) is being explored to improve symptoms in patients with refractory ischemic coronary syndromes. This study assessed the safety and feasibility of percutaneous DMR using the...